Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis-Reference-Cited by-同舟云学术

Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis

Published:2024-03 Issue:3 Volume:5 Page:e216-e225
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Manak Mark^ORCID,Gagnon Luc,Phay-Tran Steven,Levesque-Damphousse Philipa,Fabie Aymeric,Daugan Matthieu,Khan Sarwat Tahsin,Proud Pamela,Hussey Bethan,Knott Daniel,Charlton Sue,Hallis Bassam,Medigeshi Guruprasad R,Garg Neha,Anantharaj Anbalagan,Raqib Rubhana,Sarker Protim,Alam Mohammad Mamun,Rahman Mustafizur^ORCID,Murreddu Marta,Balgobind Angela,Hofman Rick,Grappi Silvia,Coluccio Rosa,Calandro Pierpaolo,Montomoli Emanuele,Mattiuzzo Giada,Prior Sandra,Le Duff Yann,Page Mark,Mitchell Jane,Schwartz Lauren M^ORCID,Bartsch Yannic C,Azizi Ali,Bernasconi Valentina,Zala Vijay,De Almeida Ana Paula,Fassoulas Helen,Agrawal Tanvi,Singh Janmejay,Roy Anjan Kumar,Berndsen Saskia,de Mooij Marina,Buitendijk Hester,Stalpers Coen,Jarju Modou,Battistella Filippo,Jeeninga Rienk,Duijsings Danny,Razzano Ilaria,Molesti Eleonora,Mazzini Livia,Boccuto Adele,Holder Angela,Mee Edward,Hurley Matthew,Padley Jennifer,Rose Nicola,Gorman Trina,Vila-Belda Jose,James Hannah,Carless Jerome

Funder

Coalition for Epidemic Preparedness Innovations

Publisher

Elsevier BV

Reference28 articles.

1. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia;Logunov;Lancet,2021

2. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients;Amit;Lancet,2021

3. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape;Tregoning;Nat Rev Immunol,2021

4. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials;Voysey;Lancet,2021

5. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2;McDonald;NPJ Vaccines,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants;2024-09-04

2. Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory Network;npj Vaccines;2024-07-16

3. Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines;Human Vaccines & Immunotherapeutics;2024-05-06

4. Unifying global efforts by CEPI’s centralized laboratory network;Frontiers in Immunology;2024-04-11